Other (Scientific journals)
(PS1481) SECOND INDUCTION CYCLE BEFORE ALLOHSCT DOES NOT IMPROVE SURVIVAL IN ADVERSE-RISK AML PATIENTS IN COMPLETE REMISSION AFTER FIRST INDUCTION
Lukas Haaksma; Gwendolyn Van Gorkom; Tom Reuvekamp et al.
2025In HemaSphere, 9 (S1)
Peer Reviewed verified by ORBi
 

Files


Full Text
Poster_EHA.pdf
Author postprint (2.95 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Acute myeloid leukemia - Clinical
Disciplines :
Hematology
Author, co-author :
Lukas Haaksma;  Amsterdam UMC location Vrije Universiteit Amsterdam > Department of Hematology
Gwendolyn Van Gorkom
Tom Reuvekamp
Andrius Žučenka
De Voeght, Adrien  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Vladimir Lazarevic
Dries Deeren
Evy Billen
Kasper Croese
Jesse Tettero
Patrycja Gradowska
Bob Löwenberg
Gert Ossenkoppele
Jeroen J. W. M. Janssen
Jacqueline Cloos
David de Leeuw
Catharina Van Elssen
More authors (7 more) Less
Language :
English
Title :
(PS1481) SECOND INDUCTION CYCLE BEFORE ALLOHSCT DOES NOT IMPROVE SURVIVAL IN ADVERSE-RISK AML PATIENTS IN COMPLETE REMISSION AFTER FIRST INDUCTION
Publication date :
June 2025
Journal title :
HemaSphere
eISSN :
2572-9241
Publisher :
Wiley
Volume :
9
Issue :
S1
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 04 November 2025

Statistics


Number of views
26 (0 by ULiège)
Number of downloads
16 (0 by ULiège)

OpenCitations
 
0
OpenAlex citations
 
1

Bibliography


Similar publications



Contact ORBi